☰

Erik Maronde - Publications

Affiliations: 
Goethe-Universität Frankfurt am Main, Frankfurt am Main, Hessen, Germany 
Area:
Neuroscience, Chronobiology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 John H, Maronde E, Forssmann WG, Meyer M, Adermann K. N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMP- and insulin-releasing capacity. European Journal of Medical Research. 13: 73-8. PMID 18424366  0.488
2007 Motzkus D, Loumi S, Cadenas C, Vinson C, Forssmann WG, Maronde E. Activation of human period-1 by PKA or CLOCK/BMAL1 is conferred by separate signal transduction pathways. Chronobiology International. 24: 783-92. PMID 17994337 DOI: 10.1080/07420520701672481  0.409
2007 Stephan S, van de Flierdt J, Loumi S, Bonaterra G, Kramer FJ, Fehr M, Tillmann HC, Forssmann WG, Maronde E. Intermittent administration of the circulating form of human parathyroid hormone (hPTH-1-37) prevents bone loss in ovariectomized rats. European Journal of Medical Research. 12: 13-20. PMID 17363353  0.38
2006 Motzkus D, Schulz-Maronde S, Heitland A, Schulz A, Forssmann WG, Jübner M, Maronde E. The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1701-2. PMID 16790530 DOI: 10.1096/fj.05-4970fje  0.457
2005 Mitrovic V, Lüss H, Nitsche K, Forssmann K, Maronde E, Fricke K, Forssmann WG, Meyer M. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial. American Heart Journal. 150: 1239. PMID 16338265 DOI: 10.1016/j.ahj.2005.01.022  0.408
2005 Kutzleb C, Busmann A, Wendland M, Maronde E. Discovery of novel regulatory peptides by reverse pharmacology: spotlight on chemerin and the RF-amide peptides metastin and QRFP. Current Protein & Peptide Science. 6: 265-78. PMID 15974952  0.302
2005 Fricke K, Schulz A, John H, Forssmann WG, Maronde E. Isolation and characterization of a novel proopiomelanocortin-derived peptide from hemofiltrate of chronic renal failure patients. Endocrinology. 146: 2060-8. PMID 15650078 DOI: 10.1210/En.2004-1097  0.514
2003 Lammerich HP, Busmann A, Kutzleb C, Wendland M, Seiler P, Berger C, Eickelmann P, Meyer M, Forssmann WG, Maronde E. Identification and functional characterization of hemorphins VV-H-7 and LVV-H-7 as low-affinity agonists for the orphan bombesin receptor subtype 3. British Journal of Pharmacology. 138: 1431-40. PMID 12721098 DOI: 10.1038/sj.bjp.0705177  0.442
2003 Krause A, Sillard R, Kleemeier B, Klüver E, Maronde E, Conejo-García JR, Forssmann WG, Schulz-Knappe P, Nehls MC, Wattler F, Wattler S, Adermann K. Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver. Protein Science : a Publication of the Protein Society. 12: 143-52. PMID 12493837 DOI: 10.1110/Ps.0213603  0.492
Show low-probability matches.